The infarct core is well represented by the acute diffusion lesion: Sustained reversal is infrequent

Journal of Cerebral Blood Flow and Metabolism

Volumn 32, Issue 1, 2012, Pages 50-56

  Campbell, Bruce C V ^a   Purushotham, Archana ^b   Christensen, Soren ^a   Desmond, Patricia M ^a   Nagakane, Yoshinari ^a   Parsons, Mark W ^c   Lansberg, Maarten G ^b   Mlynash, Michael ^b   Straka, Matus ^b   De Silva, Deidre A ^d   Olivot, Jean Marc ^b   Bammer, Roland ^b   Albers, Gregory W ^b   Donnan, Geoffrey A ^a   Davis, Stephen M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

brain ischemia; cerebrovascular disease; diffusion weighted MRI; MRI; thrombolysis

Indexed keywords

PLACEBO; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; ARTIFACT; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIFFUSION LESION REVERSAL; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HUMAN; INFARCTION; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STROKE; TISSUE PERFUSION;

AGED; BRAIN INFARCTION; DIFFUSION MAGNETIC RESONANCE IMAGING; DOUBLE-BLIND METHOD; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; PROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84855358185     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2011.102     Document Type: Article

References (33)

1. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP (2006) Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 60:508-17 (Pubitemid 44871793)
2. An H, Ford AL, Vo K, Powers WJ, Lee JM, Lin W (2011) Signal evolution and infarction risk for apparent diffusion coefficient lesions in acute ischemic stroke are both time-and perfusion-dependent. Stroke 42:1276-81
3. Butcher K, Parsons M, Allport L, Lee SB, Barber PA, Tress B, Donnan GA, Davis SM (2008) Rapid assessment of perfusion-diffusion mismatch. Stroke 39:75-81
4. Chalela JA, Kang DW, Luby M, Ezzeddine M, Latour LL, Todd JW, Dunn B, Warach S (2004) Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: insights into the pathophysiology of acute stroke in the thrombolysis era. Ann Neurol 55:105-12 (Pubitemid 38067367)
5. Chemmanam T, Campbell BCV, Christensen S, Nagakane Y, Desmond PM, Bladin CF, Parsons MW, Levi CR, Barber PA, Donnan GA, Davis SM (2010) Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch. Neurology 75:1040-7
6. Davalos A, Blanco M, Pedraza S, Leira R, Castellanos M, Pumar JM, Silva Y, Serena J, Castillo J (2004) The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology 62:2187-92 (Pubitemid 38787773)
7. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM (2008) Effects of alteplase beyond 3h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 7:299-309
8. Donnan GA, Davis SM (2008) Breaking the 3h barrier for treatment of acute ischaemic stroke. Lancet Neurol 7:981-2
9. Ebinger M, Iwanaga T, Prosser JF, De Silva DA, Christensen S, Collins M, Parsons MW, Levi CR, Bladin CF, Barber PA, Donnan GA, Davis SM (2009) Clinical-diffusion mismatch and benefit from thrombolysis 3 to 6hours after acute stroke. Stroke 40:2572-4
10. Fiehler J, Knudsen K, Kucinski T, Kidwell CS, Alger JR, Thomalla G, Eckert B, Wittkugel O, Weiller C, Zeumer H, Rother J (2004) Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke 35:514-9 (Pubitemid 38180447)
11. Gaudinski MR, Henning EC, Miracle A, Luby M, Warach S, Latour LL (2008) Establishing final infarct volume: stroke lesion evolution past 30 days is insignificant. Stroke 39:2765-8
12. Hjort N, Butcher K, Davis SM, Kidwell CS, Koroshetz WJ, Rother J, Schellinger PD, Warach S, Ostergaard L (2005) Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke 36:388-97 (Pubitemid 40170827)
13. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Vespa P, Kalafut M, Alger JR (2000) Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 47:462-9 (Pubitemid 30194602)
14. Kidwell CS, Saver JL, Starkman S, Duckwiler G, Jahan R, Vespa P, Villablanca JP, Liebeskind DS, Gobin YP, Vinuela F, Alger JR (2002) Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol 52:698-703 (Pubitemid 35403178)
15. Kranz PG, Eastwood JD (2009) Does diffusion-weighted imaging represent the ischemic core? An evidence-based systematic review. AJNR Am J Neuroradiol 30: 1206-12
16. Lansberg MG, Lee J, Christensen S, Straka M, De Silva DA, Mlynash M, Campbell BC, Bammer R, Olivot JM, Desmond P, Davis SM, Donnan GA, Albers GW. (2011) RAPID Automated Patient Selection for Reperfusion Therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Stroke 42:1608-14
17. Lansberg MG, Thijs VN, Bammer R, Olivot JM, Marks MP, Wechsler LR, Kemp S, Albers GW (2008) The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion. Stroke 39:2491-6
18. Lansberg MG, Thijs VN, Hamilton S, Schlaug G, Bammer R, Kemp S, Albers GW (2007) Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in DEFUSE. Stroke 38:1826-30 (Pubitemid 46847254)
19. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375:1695-703
20. Li F, Liu KF, Silva MD, Omae T, Sotak CH, Fenstermacher JD, Fisher M, Hsu CY, Lin W (2000) Transient and permanent resolution of ischemic lesions on diffusion-weighted imaging after brief periods of focal ischemia in rats: correlation with histopathology. Stroke 31: 946-54 (Pubitemid 30198444)
21. Ma H, Parsons M, Christensen S, Campbell B, Churilov L, Connelly A, Yan B, Bladin C, Phan T, Barber A, Read S, Hankey G, Markus R, Wijeratne T, Grimley R, Mahant N, Kleinig T, Sturm J, Lee A, Blacker D, Gerraty R, Krause M, Desmond PD, Carey L, Howell D, Davis SM, Donnan GA, on behalf of the EXTEND investigators (2011) A multicentre, randomized, double blinded, placebo controlled phase 3 study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke (in press)
22. Mishra NK, Albers GW, Davis SM, Donnan GA, Furlan AJ, Hacke W, Lees KR (2010) Mismatch-based delayed thrombolysis: a meta-analysis. Stroke 41:e25-33
23. Mlynash M, Lansberg MG, De Silva DA, Lee J, Christensen S, Straka M, Campbell BCV, Bammer R, Olivot JM, Desmond PM, Donnan GA, Davis SM, Albers GW (2011) Refining the definition of the malignant profile-insights from the defuse-EPITHET pooled data set. Stroke 42: 1270-5
24. Olivot JM, Mlynash M, Thijs VN, Purushotham A, Kemp S, Lansberg MG, Wechsler L, Bammer R, Marks MP, Albers GW (2009) Relationships between cerebral perfusion and reversibility of acute diffusion lesions in DEFUSE: insights from RADAR. Stroke 40:1692-7
25. Prosser J, Butcher K, Allport L, Parsons M, MacGregor L, Desmond P, Tress B, Davis S (2005) Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke 36:1700-4 (Pubitemid 41098765)
26. Ritzl A, Meisel S, Wittsack HJ, Fink GR, Siebler M, Modder U, Seitz RJ (2004) Development of brain infarct volume as assessed by magnetic resonance imaging (MRI): follow-up of diffusion-weighted MRI lesions. J Magn Reson Imaging 20:201-7 (Pubitemid 38970927)
27. Rivers CS, Wardlaw JM, Armitage PA, Bastin ME, Carpenter TK, Cvoro V, Hand PJ, Dennis MS (2006) Do acute diffusion-and perfusion-weighted MRI lesions identify final infarct volume in ischemic stroke? Stroke 37: 98-104 (Pubitemid 43732055)
28. Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V (2007) Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol 6:258-68 (Pubitemid 46228081)
29. Singer OC, Humpich MC, Fiehler J, Albers GW, Lansberg MG, Kastrup A, Rovira A, Liebeskind DS, Gass A, Rosso C, Derex L, Kim JS, Neumann-Haefelin T (2008) Risk for symptomatic intracerebral hemorrhage after thromboly-sis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol 63:52-60 (Pubitemid 351240551)
30. Straka M, Albers GW, Bammer R (2011) Real-time diffu-sion-perfusion mismatch analysis in acute stroke. J Magn Reson Imaging 32:1024-37
31. Tei H, Uchiyama S, Usui T (2007) Clinical-diffusion mismatch defined by NIHSS and ASPECTS in non-lacunar anterior circulation infarction. J Neurol 254: 340-6 (Pubitemid 46399196)
32. Thomas RGR, Lymer K, Armitage PA, Karaszewski B, Carpenter TK, Wardlaw JM (2010) Apparent diffusion coefficient thresholds do not identify accurately diffusion lesion volume in acute stroke patients. Cerebrovasc Dis 29(Suppl 2):498
33. Warach S (2002) Thrombolysis in stroke beyond three hours: targeting patients with diffusion and perfusion MRI. Ann Neurol 51:11-3 (Pubitemid 34027971)